Literature DB >> 12854829

Role of osteoclast extracellular signal-regulated kinase (ERK) in cell survival and maintenance of cell polarity.

Hiroaki Nakamura1, Azumi Hirata, Takehito Tsuji, Toshio Yamamoto.   

Abstract

UNLABELLED: Morphological changes of osteoclasts by a MEK1 inhibitor, PD98059, were investigated to clarify a role of ERK. PD98059 promoted apoptosis of osteoclasts and the loss of ruffled borders. This study supports the importance of ERK in survival and polarity of osteoclasts.
INTRODUCTION: Extracellular signal-regulated kinase (ERK) is a mitogen activated protein kinase (MAPK) that has been reported to play a role in the survival and apoptosis of osteoclasts. However, the precise signal transduction mechanism is not fully understood. The aim of this study was to clarify the role of ERK in osteoclasts by histological analysis.
MATERIALS AND METHODS: Using a rat calvarial organ culture system, the inhibition of ERK phosphorylation by PD98059, a MAPK/ERK kinase 1 (MEK1) inhibitor, was assayed by immunoblotting. Morphological changes in osteoclasts induced by PD98059 were elucidated by light and electron microscopy. The cellular localization of ERK was also determined by immunoelectron microscopy.
RESULTS: PD98059 inhibited phosphorylated ERK after a 1-h incubation. Ultrastructural study demonstrated that PD98059 induced the accumulation of vesicles and vacuoles in osteoclasts and the loss of ruffled border at 1 h. At 3 h, some osteoclasts showed apoptosis with nuclear condensation, and at 6 h after PD98059 treatment, many osteoclasts were detached from the bone surface and had lost their cell polarity. Electron microscopic immunohistochemistry revealed that ERK was mainly localized in the cytoplasm of clear zones in control osteoclasts, but apoptotic osteoclasts also showed immunoreactivity in clear zone-like structures in contact with osteoblast-lineage cells.
CONCLUSION: These findings indicate that ERK in osteoclasts is involved in their survival and may be involved in the formation of a ruffled border and the maintenance of cell polarity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854829     DOI: 10.1359/jbmr.2003.18.7.1198

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  25 in total

1.  Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.

Authors:  Ran Gu; Leilani L Santos; Devi Ngo; HuaPeng Fan; Preetinder P Singh; Gunter Fingerle-Rowson; Richard Bucala; Jiake Xu; Julian M W Quinn; Eric F Morand
Journal:  Cytokine       Date:  2015-01-31       Impact factor: 3.861

2.  Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide.

Authors:  Takayuki Yamaguchi; Reina Kakefuda; Atsuo Tanimoto; Yoshihiro Watanabe; Nobuyuki Tajima
Journal:  Inflamm Res       Date:  2012-01-14       Impact factor: 4.575

3.  Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.

Authors:  Ning Wang; Bernard Robaye; Ankita Agrawal; Timothy M Skerry; Jean-Marie Boeynaems; Alison Gartland
Journal:  Mol Endocrinol       Date:  2011-11-22

4.  Decreased bone mineralization in children with Noonan syndrome: another consequence of dysregulated RAS MAPKinase pathway?

Authors:  Kiran S Choudhry; Monica Grover; Alyssa A Tran; E O'Brian Smith; Kenneth J Ellis; Brendan H Lee
Journal:  Mol Genet Metab       Date:  2012-04-11       Impact factor: 4.797

5.  Acyloxyacyl hydrolase deficiency induces chronic inflammation and bone loss in male mice.

Authors:  Xu Cheng; Xiaoting Song; Zhiyan Li; Chiting Yuan; Xinhuan Lei; Mingxuan Feng; Zhenghua Hong; Liwei Zhang; Dun Hong
Journal:  J Mol Med (Berl)       Date:  2022-09-16       Impact factor: 5.606

6.  Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells.

Authors:  Dong-Zhu Li; Qing-Xiang Zhang; Xiao-Xian Dong; Huai-Dong Li; Xin Ma
Journal:  J Bone Miner Metab       Date:  2013-11-07       Impact factor: 2.626

7.  Breast cancer-derived factors stimulate osteoclastogenesis through the Ca2+/protein kinase C and transforming growth factor-beta/MAPK signaling pathways.

Authors:  Kerstin Tiedemann; Osama Hussein; Gulzhakhan Sadvakassova; Yubin Guo; Peter M Siegel; Svetlana V Komarova
Journal:  J Biol Chem       Date:  2009-09-30       Impact factor: 5.157

8.  The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo.

Authors:  Lauren S Whyte; Erik Ryberg; Natalie A Sims; Susan A Ridge; Ken Mackie; Peter J Greasley; Ruth A Ross; Michael J Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-03       Impact factor: 11.205

9.  Notopterol Attenuates Estrogen Deficiency-Induced Osteoporosis via Repressing RANKL Signaling and Reactive Oxygen Species.

Authors:  Delong Chen; Qingqing Wang; Ying Li; Ping Sun; Vincent Kuek; Jinbo Yuan; Junzheng Yang; Longfei Wen; Haibin Wang; Jiake Xu; Peng Chen
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

10.  Bone resorption is regulated by cell-autonomous negative feedback loop of Stat5-Dusp axis in the osteoclast.

Authors:  Jun Hirose; Hironari Masuda; Naoto Tokuyama; Yasunori Omata; Takumi Matsumoto; Tetsuro Yasui; Yuho Kadono; Lothar Hennighausen; Sakae Tanaka
Journal:  J Exp Med       Date:  2013-12-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.